Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05837_nanopub.RAE5if09m72s5lMpXVqZ0kBvGQOWwnNOrI2wKqNt6_pNU#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05837 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05837 label "OSI-7836 [drugbank:DB05837]" assertion.
- drugbank:DB05837 seeAlso DB05837 assertion.
- drugbank:DB05837 description "OSI-7836 is a member of the nucleoside class of cytotoxic drugs of which gemcitabine is the market leader. OSI Pharmaceuticals develops OSI-7836 as a next-generation gemcitabine. The anti-tumor activity of OSI-7836 appeares to be less schedule dependent than gemcitabine. It is also more active than ara-C (another clinically used nucleoside analog) in all nine models and more active than either paclitaxel or cisplatin in the two lung xenograft models tested. This drug shows no unexpected toxicities; those observed appeared to be similar to other nucleoside agents." assertion.
- drugbank:DB05837 identifier "drugbank:DB05837" assertion.
- drugbank:DB05837 title "OSI-7836" assertion.
- drugbank:DB05837 drugbank_vocabulary:x-pubchemcompound pubchem.compound:3037115 assertion.
- drugbank:DB05837 drugbank_vocabulary:x-chemspider chemspider:2300942 assertion.
- drugbank:DB05837 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05837 drugbank_vocabulary:drugbank-id "DB05837" assertion.
- drugbank:DB05837 bio2rdf_vocabulary:x-identifiers.org DB05837 assertion.
- drugbank:DB05837 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05837" assertion.
- drugbank:DB05837 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05837 bio2rdf_vocabulary:identifier "DB05837" assertion.